Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

amdipharm limited, Írsko - maprotilín - 30 - antidepressiva

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

amdipharm limited, Írsko - maprotilín - 30 - antidepressiva

Європейський Союз - словацька - EMA (European Medicines Agency)

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotické činidlá - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Європейський Союз - словацька - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - imunosupresíva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Європейський Союз - словацька - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - obezita - prípravky proti obezite, okrem diétne výrobky - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

Європейський Союз - словацька - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovírusové infekcie - antivirotiká na systémové použitie - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). je treba vziať do úvahy oficiálne usmernenie o vhodnom používaní protivírusové agentov.

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica

Словаччина - словацька - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica